Phase II study of perifosine in previously untreated patients with metastatic melanoma.

Ernst, D Scott; Eisenhauer, Elizabeth; Wainman, Nancy; Davis, Mary; Lohmann, Reinhard; Baetz, Tara; Belanger, Karl; Smylie, Michael

Ernst, D Scott; Eisenhauer, Elizabeth; Wainman, Nancy; Davis, Mary; Lohmann, Reinhard; Baetz, Tara; Belanger, Karl; Smylie, Michael.

Affiliation

Ernst DS; London Regional Cancer Centre, 790 Commissioners Rd East, London, ON N6A 4L6, UK. scott.ernst@lrcc.on.ca

Invest New Drugs ; 23(6): 569-75, 2005 Dec.

Article in En | MEDLINE | ID: mdl-16034524

Subject(s)

Melanoma/drug therapy; Phosphorylcholine/analogs & derivatives; Adult; Aged; Aged, 80 and over; Arthralgia/chemically induced; Chondrocalcinosis/chemically induced; Female; Humans; Liver Neoplasms/drug therapy; Liver Neoplasms/secondary; Lung Neoplasms/drug therapy; Lung Neoplasms/secondary; Lymphatic Metastasis; Melanoma/secondary; Middle Aged; Phosphorylcholine/adverse effects; Phosphorylcholine/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phosphorylcholine / Melanoma Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Invest New Drugs Year: 2005 Document type: Article Affiliation country: United kingdom Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links